Oligodendroglioma epidemiology and demographics: Difference between revisions
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
| Line 10: | Line 10: | ||
*Oligodendroglioma, although rare, is the third most common [[glioma]]<ref name="epidemiology">Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref> | *Oligodendroglioma, although rare, is the third most common [[glioma]]<ref name="epidemiology">Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma</ref> | ||
*Oligodendroglioma accounts for 2%–5% of [[brain tumor|primary brain tumors]] and 5%–18% of all [[glioma|glial neoplasms]] | *Oligodendroglioma accounts for 2%–5% of [[brain tumor|primary brain tumors]] and 5%–18% of all [[glioma|glial neoplasms]] | ||
*Oligodendroglioma and anaplastic oligodendroglioma, together are one-tenth as common as glioblastoma (most commonly occurring malignant primary brain tumor in adults) | |||
===Incidence=== | ===Incidence=== | ||
Revision as of 14:03, 6 May 2019
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma epidemiology and demographics |
|
Risk calculators and risk factors for Oligodendroglioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]
Overview
Oligodendroglioma, although rare, is the third most common glioma. The incidence of oligodendroglioma and anaplastic oligodendroglioma is estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively. Oligodendroglioma is a disease that tends to affect the middle-aged adult population. Oligodendroglioma most commonly occurs in the 4th and 5th decade of life. Males are more commonly affected with oligodendroglioma than females. The male to female ratio is approximately 2 to 1. Oligodendroglioma usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop oligodendroglioma.
Epidemiology and Demographics
Prevalence
- Oligodendroglioma, although rare, is the third most common glioma[1]
- Oligodendroglioma accounts for 2%–5% of primary brain tumors and 5%–18% of all glial neoplasms
- Oligodendroglioma and anaplastic oligodendroglioma, together are one-tenth as common as glioblastoma (most commonly occurring malignant primary brain tumor in adults)
Incidence
- The incidence of oligodendroglioma and anaplastic oligodendroglioma is estimated to be 0.32 and 0.17 cases per 100,000 individuals in the United States, respectively[2][3]
Age
- Oligodendroglioma is a disease that tends to affect the middle-aged adult population[1]
- Oligodendroglioma most commonly occurs in the 4th and 5th decade of life
- The median age at diagnosis is 47 years[4]
Gender
- Males are more commonly affected with oligodendroglioma than females. The male to female ratio is approximately 2 to 1[5]
Race
- Oligodendroglioma usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop oligodendroglioma[6]
References
- ↑ 1.0 1.1 Epidemiology of oligodendroglioma. Dr Henry Knipe and Dr. Frank Gaillard et al. http://radiopaedia.org/articles/oligodendroglioma
- ↑ McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H; et al. (2011). "Risk factors for oligodendroglial tumors: a pooled international study". Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMC 3064625. PMID 21149253.
- ↑ Ohgaki H, Kleihues P (2005). "Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas". J Neuropathol Exp Neurol. 64 (6): 479–89. PMID 15977639.
- ↑ Mørk SJ, Lindegaard KF, Halvorsen TB, Lehmann EH, Solgaard T, Hatlevoll R; et al. (1985). "Oligodendroglioma: incidence and biological behavior in a defined population". J Neurosurg. 63 (6): 881–9. doi:10.3171/jns.1985.63.6.0881. PMID 4056902.
- ↑ Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A (2015). "Clinical management of grade III oligodendroglioma". Cancer Manag Res. 7: 213–23. doi:10.2147/CMAR.S56975. PMC 4524382. PMID 26251628.
- ↑ Patterns by Gender for Selected Histologies CBTRUS Statistical Report: NPCR and SEER Data from 2004-2006. CBTRUS.org 2015. http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf